Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.

Journal: PLOS digital health

Publication date: 

Journal: PLOS digital health

Publication Year: 

Authors & Co-authors:  De Brouwer Edward E Becker Thijs T Werthen-Brabants Lorin L Dewulf Pieter P Iliadis Dimitrios D Dekeyser Cathérine C Laureys Guy G Van Wijmeersch Bart B Popescu Veronica V Dhaene Tom T

Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.

Journal: Journal of neurology, neurosurgery, and psychiatry

Publication date: 2022

Journal: Journal of neurology, neurosurgery, and psychiatry

Publication Year: 2022

Authors & Co-authors:  Signori Alessio A Lorscheider Johannes J Vukusic Sandra S Trojano Maria M Iaffaldano Pietro P Hillert Jan J Hyde Robert R Pellegrini Fabio F Magyari Melinda M Koch-Henriksen Nils N

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.

Journal: JAMA neurology

Publication date: 2023

Journal: JAMA neurology

Publication Year: 2023

Authors & Co-authors:  Kalincik Tomas T Sharmin Sifat S Roos Izanne I Freedman Mark S MS Atkins Harold H Burman Joachim J Massey Jennifer J Sutton Ian I Withers Barbara B Macdonell Richard R

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

Journal: Journal of medical economics

Publication date: 2023

Journal: Journal of medical economics

Publication Year: 2023

Authors & Co-authors:  Spelman T T Herring W L WL Acosta C C Hyde R R Jokubaitis V G VG Pucci E E Lugaresi A A Laureys G G Havrdova E K EK Horakova D D